IBD & Intestinal Disorders
Conference Coverage
Breakthrough COVID-19 milder in vaccinated patients with IBD
Patients with inflammatory bowel disease who are vaccinated but still develop COVID experience milder disease than those who are unvaccinated.
News
Gut bacteria linked with long COVID
News
AGA Clinical Practice Update: Managing pain in gut-brain interaction disorders
New guidance emphasizes patient education and patient-physician collaboration.
News
AGA Clinical Practice Update: Expert Review on IBD dysplasia surveillance, management
The 14 best practice advice statements cover a variety of topics, including appropriate lesion terminology and characterization.
Article
CAG Clinical Practice Guideline: Vaccination in patients with IBD
The guideline is composed of recommendations drawn from a broader body of data than prior publications on the same topic.
News
PPIs could be bad news for oral cancer therapies
GIs may want to be mindful of prescribing PPIs for patients with cancer because they may adversely affect concomitant oral therapies.
News
Novel oral inhibitor may block intestinal damage in celiac disease
Randomized, phase 2 trial explored safety and efficacy of ZED1227, a transglutaminase inhibitor, after 6 weeks at three different doses.
News
Psychological difficulties persist among patients with IBD
“Simple screening tools may help with this, but then there need to be resources to support interventions,” said Dr. Kim L. Isaacs.
Conference Coverage
Vedolizumab looks safer than anti-TNF drugs in older adults with IBD
An analysis of a Medicare claims database finds vedolizumab is associated with efficacy similar to that of anti-TNF inhibitors, with fewer...
Article
AGA Clinical Practice Update: Diagnosis and management of immune checkpoint inhibitor enterocolitis and hepatitis
Some studies have suggested that colitis, with or without enteritis, affects up to 40% of patients depending on pathway targeted by the treatment...